Logo image of AKAST.OL

AKASTOR ASA (AKAST.OL) Stock Fundamental Analysis

OSL:AKAST - Euronext Oslo - NO0010215684 - Common Stock - Currency: NOK

12.38  +0.06 (+0.49%)

Fundamental Rating

4

AKAST gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Energy Equipment & Services industry. While AKAST has a great health rating, its profitability is only average at the moment. AKAST has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKAST was profitable.
AKAST had a positive operating cash flow in the past year.
In multiple years AKAST reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: AKAST reported negative operating cash flow in multiple years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

AKAST's Return On Assets of 13.62% is amongst the best of the industry. AKAST outperforms 91.67% of its industry peers.
AKAST's Return On Equity of 15.67% is fine compared to the rest of the industry. AKAST outperforms 69.44% of its industry peers.
AKAST's Return On Invested Capital of 0.55% is on the low side compared to the rest of the industry. AKAST is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
ROA 13.62%
ROE 15.67%
ROIC 0.55%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

AKAST's Profit Margin of 243.26% is amongst the best of the industry. AKAST outperforms 100.00% of its industry peers.
AKAST's Profit Margin has improved in the last couple of years.
AKAST has a Operating Margin (12.08%) which is comparable to the rest of the industry.
AKAST has a Gross Margin of 26.97%. This is in the better half of the industry: AKAST outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of AKAST has declined.
Industry RankSector Rank
OM 12.08%
PM (TTM) 243.26%
GM 26.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

7

2. Health

2.1 Basic Checks

AKAST has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AKAST has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AKAST has more shares outstanding
Compared to 1 year ago, AKAST has an improved debt to assets ratio.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

AKAST has a debt to FCF ratio of 0.24. This is a very positive value and a sign of high solvency as it would only need 0.24 years to pay back of all of its debts.
The Debt to FCF ratio of AKAST (0.24) is better than 94.44% of its industry peers.
AKAST has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AKAST (0.05) is better than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.24
Altman-Z N/A
ROIC/WACC0.05
WACC10.28%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.59 indicates that AKAST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.59, AKAST belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
A Quick Ratio of 2.59 indicates that AKAST has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.59, AKAST belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

AKAST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 136.99%, which is quite impressive.
The Earnings Per Share has been growing by 75.95% on average over the past years. This is a very strong growth
AKAST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.41%.
AKAST shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -44.12% yearly.
EPS 1Y (TTM)136.99%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-133.17%
Revenue 1Y (TTM)-58.41%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%76.74%

3.2 Future

Based on estimates for the next years, AKAST will show a very negative growth in Earnings Per Share. The EPS will decrease by -51.20% on average per year.
The Revenue is expected to decrease by -32.24% on average over the next years. This is quite bad
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.92, which indicates a rather cheap valuation of AKAST.
AKAST's Price/Earnings ratio is rather cheap when compared to the industry. AKAST is cheaper than 91.67% of the companies in the same industry.
AKAST is valuated cheaply when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.04, AKAST is valued on the expensive side.
Based on the Price/Forward Earnings ratio, AKAST is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
AKAST is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.92
Fwd PE 24.04
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKAST is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, AKAST is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.98
EV/EBITDA 41.45
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AKAST's earnings are expected to decrease with -51.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-51.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AKAST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKASTOR ASA

OSL:AKAST (6/20/2025, 7:00:00 PM)

12.38

+0.06 (+0.49%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-10 2025-07-10
Inst Owners17.34%
Inst Owner ChangeN/A
Ins Owners1.64%
Ins Owner ChangeN/A
Market Cap3.39B
Analysts86
Price Target21.42 (73.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)0.44%
Revenue beat(4)3
Avg Revenue beat(4)4.16%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)11.13%
Revenue beat(8)4
Avg Revenue beat(8)-2.7%
Revenue beat(12)6
Avg Revenue beat(12)-13.46%
Revenue beat(16)9
Avg Revenue beat(16)-11.72%
PT rev (1m)-2.33%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 3.92
Fwd PE 24.04
P/S 9.53
P/FCF 1.98
P/OCF 1.88
P/B 0.61
P/tB 0.61
EV/EBITDA 41.45
EPS(TTM)3.16
EY25.53%
EPS(NY)0.52
Fwd EY4.16%
FCF(TTM)6.27
FCFY50.62%
OCF(TTM)6.6
OCFY53.3%
SpS1.3
BVpS20.18
TBVpS20.18
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 15.67%
ROCE 0.71%
ROIC 0.55%
ROICexc 0.58%
ROICexgc 0.58%
OM 12.08%
PM (TTM) 243.26%
GM 26.97%
FCFM 482.3%
ROA(3y)5.41%
ROA(5y)4.53%
ROE(3y)4.92%
ROE(5y)4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y77.83%
PM growth 5Y213.61%
GM growth 3Y-21.44%
GM growth 5Y-8.67%
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.24
Debt/EBITDA 3.31
Cap/Depr 260%
Cap/Sales 25.56%
Interest Coverage 250
Cash Conversion 2317.95%
Profit Quality 198.27%
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z N/A
F-Score6
WACC10.28%
ROIC/WACC0.05
Cap/Depr(3y)202.64%
Cap/Depr(5y)136.86%
Cap/Sales(3y)20%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)136.99%
EPS 3Y21.55%
EPS 5Y75.95%
EPS Q2Q%-133.17%
EPS Next Y-90.48%
EPS Next 2Y-51.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.41%
Revenue growth 3Y-31.61%
Revenue growth 5Y-44.12%
Sales Q2Q%76.74%
Revenue Next Year-58.39%
Revenue Next 2Y-32.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-92.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y884.02%
FCF growth 3YN/A
FCF growth 5Y42.34%
OCF growth 1Y956.87%
OCF growth 3YN/A
OCF growth 5Y34.38%